SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] [amend]
SEC Accession No. 0001157523-12-000123
Filing Date
2012-01-12
Accepted
2012-01-12 17:17:53
Documents
6
Period of Report
2009-12-31
Filing Date Changed
2012-01-12

Document Format Files

Seq Description Document Type Size
1 TARO PHARMACEUTICAL INDUSTRIES LTD. 20-F/A a50130507.htm 20-F/A 1874073
2 EXHIBIT 12.1 a50130507ex12-1.htm EX-12.1 15829
3 EXHIBIT 12.2 a50130507ex12-2.htm EX-12.2 15664
4 EXHIBIT 13 a50130507ex13.htm EX-13 12228
5 HEADER header.jpg GRAPHIC 7249
6 FOOTER footer.jpg GRAPHIC 14207
  Complete submission text file 0001157523-12-000123.txt   1948681
Mailing Address THREE SKYLINE DR HAWTHORNE NY 10532
Business Address 14 HAKTOR ST HAIFA BAY L3 26110 9143459001
TARO PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000906338 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 000-22286 | Film No.: 12524811
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1